MLN1202
Term · Oncology and biomedicine · MLC-T-ONC-005435
A substance being studied as a treatment for atherosclerosis (a build-up of fat in the arteries). It is also being studied in the treatment of cancers that spread to the bone. MLN1202 binds to a protein called CCR2, which is found on the surface of certain bone cells, white blood cells, and cancer cells. MLN1202 blocks the action of a substance that is involved in keeping healthy bone mass. It may help keep the cancer cells from spreading to and growing in the bone. It is a type of monoclonal antibody. Also called anti-CCR2 monoclonal antibody MLN1202.
| Identifier | MLC-T-ONC-005435 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | anti-CCR2 monoclonal antibody MLN1202 |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-005435",
"term": "MLN1202",
"field": "Oncology and biomedicine",
"definition": "A substance being studied as a treatment for atherosclerosis (a build-up of fat in the arteries). It is also being studied in the treatment of cancers that spread to the bone. MLN1202 binds to a protein called CCR2, which is found on the surface of certain bone cells, white blood cells, and cancer cells. MLN1202 blocks the action of a substance that is involved in keeping healthy bone mass. It may help keep the cancer cells from spreading to and growing in the bone. It is a type of monoclonal antibody. Also called anti-CCR2 monoclonal antibody MLN1202.",
"expansions": [
"anti-CCR2 monoclonal antibody MLN1202"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/mln1202/"
}
Record 11,142 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.